396 related articles for article (PubMed ID: 36334289)
1. Focused ultrasound-mediated blood-brain barrier opening in Alzheimer's disease: long-term safety, imaging, and cognitive outcomes.
Rezai AR; Ranjan M; Haut MW; Carpenter J; D'Haese PF; Mehta RI; Najib U; Wang P; Claassen DO; Chazen JL; Krishna V; Deib G; Zibly Z; Hodder SL; Wilhelmsen KC; Finomore V; Konrad PE; Kaplitt M;
J Neurosurg; 2023 Jul; 139(1):275-283. PubMed ID: 36334289
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound.
Rezai AR; Ranjan M; D'Haese PF; Haut MW; Carpenter J; Najib U; Mehta RI; Chazen JL; Zibly Z; Yates JR; Hodder SL; Kaplitt M
Proc Natl Acad Sci U S A; 2020 Apr; 117(17):9180-9182. PubMed ID: 32284421
[TBL] [Abstract][Full Text] [Related]
3. Extensive frontal focused ultrasound mediated blood-brain barrier opening for the treatment of Alzheimer's disease: a proof-of-concept study.
Park SH; Baik K; Jeon S; Chang WS; Ye BS; Chang JW
Transl Neurodegener; 2021 Nov; 10(1):44. PubMed ID: 34740367
[TBL] [Abstract][Full Text] [Related]
4. β-Amyloid Plaque Reduction in the Hippocampus After Focused Ultrasound-Induced Blood-Brain Barrier Opening in Alzheimer's Disease.
D'Haese PF; Ranjan M; Song A; Haut MW; Carpenter J; Dieb G; Najib U; Wang P; Mehta RI; Chazen JL; Hodder S; Claassen D; Kaplitt M; Rezai AR
Front Hum Neurosci; 2020; 14():593672. PubMed ID: 33132889
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease.
Mehta RI; Carpenter JS; Mehta RI; Haut MW; Ranjan M; Najib U; Lockman P; Wang P; D'haese PF; Rezai AR
Radiology; 2021 Mar; 298(3):654-662. PubMed ID: 33399511
[TBL] [Abstract][Full Text] [Related]
6. Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device.
Epelbaum S; Burgos N; Canney M; Matthews D; Houot M; Santin MD; Desseaux C; Bouchoux G; Stroer S; Martin C; Habert MO; Levy M; Bah A; Martin K; Delatour B; Riche M; Dubois B; Belin L; Carpentier A
Alzheimers Res Ther; 2022 Mar; 14(1):40. PubMed ID: 35260178
[TBL] [Abstract][Full Text] [Related]
7. Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients.
Karakatsani ME; Ji R; Murillo MF; Kugelman T; Kwon N; Lao YH; Liu K; Pouliopoulos AN; Honig LS; Duff KE; Konofagou EE
Theranostics; 2023; 13(12):4102-4120. PubMed ID: 37554284
[No Abstract] [Full Text] [Related]
8. Transcranial Blood-Brain Barrier Opening in Alzheimer's Disease Patients Using a Portable Focused Ultrasound System with Real-Time 2-D Cavitation Mapping.
Bae S; Liu K; Pouliopoulos AN; Ji R; Jiménez-Gambín S; Yousefian O; Kline-Schoder AR; Batts AJ; Tsitsos FN; Kokossis D; Mintz A; Honig LS; Konofagou EE
medRxiv; 2024 May; ():. PubMed ID: 38196636
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated blood-brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer's disease.
Mehta RI; Carpenter JS; Mehta RI; Haut MW; Wang P; Ranjan M; Najib U; D'Haese PF; Rezai AR
Fluids Barriers CNS; 2023 Jun; 20(1):46. PubMed ID: 37328855
[TBL] [Abstract][Full Text] [Related]
10. Blood-brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
Meng Y; Goubran M; Rabin JS; McSweeney M; Ottoy J; Pople CB; Huang Y; Storace A; Ozzoude M; Bethune A; Lam B; Swardfager W; Heyn C; Abrahao A; Davidson B; Hamani C; Aubert I; Zetterberg H; Ashton NJ; Karikari TK; Blennow K; Black SE; Hynynen K; Lipsman N
Brain; 2023 Mar; 146(3):865-872. PubMed ID: 36694943
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Safety of Focused Ultrasound-Induced Blood-Brain Barrier Opening in a Natural Canine Model of Aging.
O'Reilly MA; Jones RM; Barrett E; Schwab A; Head E; Hynynen K
Theranostics; 2017; 7(14):3573-3584. PubMed ID: 28912896
[No Abstract] [Full Text] [Related]
14. Focused Ultrasound-Induced Blood-Brain Barrier Opening Enhances GSK-3 Inhibitor Delivery for Amyloid-Beta Plaque Reduction.
Hsu PH; Lin YT; Chung YH; Lin KJ; Yang LY; Yen TC; Liu HL
Sci Rep; 2018 Aug; 8(1):12882. PubMed ID: 30150769
[TBL] [Abstract][Full Text] [Related]
15. Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates.
Pouliopoulos AN; Kwon N; Jensen G; Meaney A; Niimi Y; Burgess MT; Ji R; McLuckie AJ; Munoz FA; Kamimura HAS; Teich AF; Ferrera VP; Konofagou EE
Sci Rep; 2021 Jul; 11(1):15043. PubMed ID: 34294761
[TBL] [Abstract][Full Text] [Related]
16. Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells.
Sun T; Shi Q; Zhang Y; Power C; Hoesch C; Antonelli S; Schroeder MK; Caldarone BJ; Taudte N; Schenk M; Hettmann T; Schilling S; McDannold NJ; Lemere CA
J Control Release; 2021 Aug; 336():443-456. PubMed ID: 34186148
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil recruitment and leukocyte response following focused ultrasound and microbubble mediated blood-brain barrier treatments.
Poon C; Pellow C; Hynynen K
Theranostics; 2021; 11(4):1655-1671. PubMed ID: 33408773
[No Abstract] [Full Text] [Related]
18. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
[TBL] [Abstract][Full Text] [Related]
19. Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study.
Pineda-Pardo JA; Gasca-Salas C; Fernández-Rodríguez B; Rodríguez-Rojas R; Del Álamo M; Obeso I; Hernández-Fernández F; Trompeta C; Martínez-Fernández R; Matarazzo M; Mata-Marín D; Guida P; Duque A; Albillo D; Plaza de Las Heras I; Montero JI; Foffani G; Toltsis G; Rachmilevitch I; Blesa J; Obeso JA
Mov Disord; 2022 Oct; 37(10):2057-2065. PubMed ID: 35765711
[TBL] [Abstract][Full Text] [Related]
20. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
